Tarlox and Sotorasib in Patients With KRAS G12C Mutations

Clinical trial NCT05313009 · TERMINATED

Trial details

NCT number: NCT05313009
Sponsor: Medical University of South Carolina
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2022-03-07
Primary completion: 2023-07-07
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.